Use of relaxin in the treatment of bradycardia
US5478807A · kind A · utility
55Cited by
6References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 23, 1992 |
| Grant date | Dec 26, 1995 |
| Priority date | — |
| Expiry date | Jun 23, 2012 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/72
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns the use of relaxin or another compound capable of specific binding of a relaxin receptor in the heart in the cardiovascular therapy, and specifically in the treatment of acute and chronic heart failure or of a condition characterized by pathologically low heart rate. The invention further concerns the treatment of neurodegenerative diseases using relaxin or other compounds capable of selectively binding a relaxin receptor in the brain.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.